Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

9 Oct 2018 08:23

RNS Number : 3946D
Applied Graphene Materials PLC
09 October 2018
 

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Board Appointment

Applied Graphene Materials, the producer of specialty graphene materials, announces the appointment of David Jonathan Blain, aged 56, to the Board as Chief Financial Officer of the Company, with effect from 22nd October 2018. David is a chartered accountant with over 30 years' experience, who having worked in practice with Price Waterhouse has operated for many years at Board level in both fully listed and AIM companies.

David joins AGM from Nanoco Group plc, a nanotechnology business specialising in semiconductor material licences and products for the display, lighting and bio diagnostic imaging markets, where he operated as Chief Financial Officer and Company Secretary. During his time at Nanoco David led the finance team and, in addition to overseeing day to day finance functions, successfully completed an £8 million fundraise in November 2017. Prior to this he spent seven years at Inspired Capital plc (formerly Renovo Group plc), a fully listed biotech company which, following cessation of biotech activities, acquired a company lending funds to small businesses. Operating as CFO and Company Secretary he played a significant role in the acquisition of Ultimate Finance Group plc. During his tenure the business increased its market capitalisation to £150m, employing 170 staff prior to its takeover by Tavistock in 2015.

The appointment of David comes at a period of significant planned development for the Company as it looks to generate and secure additional and ever larger orders.

Adrian Potts Chief Executive Officer, commented:

"We are delighted to welcome David to Applied Graphene Materials. His extensive commercial and operational experience coupled with his background in an early stage nanotechnology business will be a huge asset to the Company as it moves into the next phase of development. Additionally, having spent a considerable amount of time working in manufacturing and listed companies, setting strategy and growing businesses and teams we believe this will be of significant benefit as we look to advance the Company."

ADDITIONAL INFORMATION

Other than as set out below, there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Blain's appointment.

Mr David Jonathan Blain, aged 56 is, or has been, a director of the following companies during the previous five years:

Current directorships/partnerships

Past directorships/partnerships

 

· Blain Associates Limited

 

 

· Nanoco Group Plc

· Nanoco Technologies Limited

· Nanoco Tech Limited

· Nanoco Life Sciences Limited

· Nanoco 2D Material Limited

· Dysons Sales Ledger Management Services Limited

· Ultimate Construction Finance Limited

· Ultimate Business Finance Limited

· Ultimate Finance Group Limited

· Ultimate Accelerated Payments Limited

· Ultimate Factors Limited

· Ultimate Bridging Finance Limited

· Ultimate Asset Financing Limited

· Ultimate Finance Limited

· Ultimate Trade Finance Limited

· Ultimate Finance Holdings Limited

· Ashley Finance Limited

· BIZHELP24 Limited

· Renovo Technologies Limited

· Renovo Ltd

· Broken Nation Films Ltd

· Reinnervate Limited

 

 

Ends

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts Chief Executive Officer

 

N+1 Singer +44 (0) 207 496 3000

Richard Lindley / James White

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFSFSWUFASEES
Date   Source Headline
25th Apr 20187:00 amRNSIssue of share options to Directors
18th Apr 20188:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSInterim Results
8th Mar 20187:00 amRNSCollaboration with SHD and Magna Exteriors
1st Feb 20187:00 amRNSBoard Change
15th Jan 20189:22 amRNSHolding(s) in Company
10th Jan 20185:30 pmRNSHolding(s) in Company
10th Jan 20184:40 pmRNSSecond Price Monitoring Extn
10th Jan 20184:35 pmRNSPrice Monitoring Extension
8th Jan 20181:21 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSResult of AGM
3rd Jan 20187:00 amRNSAGM Statement
12th Dec 20177:00 amRNSNotice of AGM
7th Nov 20179:47 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding
30th Oct 20171:15 pmRNSResults of Open Offer and General Meeting
12th Oct 20175:19 pmRNSPosting of Circular and Notice of General Meeting
10th Oct 20176:16 pmRNSFurther Details on the Fundraising
10th Oct 201711:41 amRNSClose of Accelerated Bookbuild
10th Oct 201711:00 amRNSPrice Monitoring Extension
10th Oct 20177:05 amRNSProposed Placing by Accelerated Bookbuild
10th Oct 20177:00 amRNSPreliminary Results
22nd Aug 20177:00 amRNSInvestor Site Visit
24th May 20177:00 amRNSNew Graphene Delivery Technology & Trading Update
22nd May 20174:18 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSInterim Results
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20174:40 pmRNSSecond Price Monitoring Extn
5th Apr 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSGrant of Options
30th Jan 20177:00 amRNSShare Purchase by CFO-Designate
25th Jan 20177:00 amRNSBoard & Operational Appointments
20th Dec 20167:00 amRNSAGM Statement
31st Oct 20167:01 amRNSDirector/PDMR Shareholding
31st Oct 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSFinal Results
14th Oct 20167:00 amRNSFirst Production Order
12th Aug 20167:38 amRNSExercise of Share Options and PDMR Dealing
12th Aug 20167:00 amRNSDirectorate Change
12th Aug 20167:00 amRNSPeriod end trading update and notice of results
8th Aug 20167:00 amRNSProduct Development and New JDA
23rd Mar 20167:00 amRNSInterim Results
26th Jan 20163:21 pmRNSHolding(s) in Company
26th Jan 201612:15 pmRNSResult of AGM
25th Jan 20167:00 amRNSAGM Statement
22nd Jan 201610:33 amRNSHolding(s) in Company
13th Jan 20169:08 amRNSHolding(s) in Company
11th Jan 20163:42 pmRNSIssue of share options to Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.